42K members
15.3K photos
9 videos
87 files
8.67K links
информационная поддержка для трейдеров и инвесторов

связь - @MarketTwits_info
связь -
Download Telegram
to view and join the conversation
⚠️☢️#VERI #крипто
добро пожаловать в мир shit-коинов: Курс Veritaseum упал на 70% на фоне обвинений SEC в мошенничестве
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:


#IFRX +35% InflaRx N.V. -after reporting positive results from the open label extension part of the SHINE study for IFX-1 in hidradenitis suppurativa.

#DXCM +21% DexCom, Inc. -after the company posted upbeat Q3 results and raised FY2019 sales guidance.

#LXRX +16% Lexicon Pharmaceuticals, Inc. - following Q3 results.

#LVGO +13% Livongo Health, Inc. -after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 sales guidance and issued Q4 sales guidance above analyst estimates.

#EYE +13% National Vision Holdings, Inc. - following Q3 results.

#TXMD +10% TherapeuticsMD, Inc.

#SAIL +9% SailPoint Technologies Holdings, Inc. - reported better-than-expected Q3 EPS and sales results.

#ELF +9% e.l.f. Beauty, Inc. - after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY20 EPS and sales guidance.

#MT +8% ArcelorMittal - after the company reported Q3 results.

#SONO +8% Sonos, Inc.

#IQ +7% iQIYI, Inc. -reported better-than-expected Q3 EPS results.

#QCOM +6% QUALCOMM Incorporated - reported better-than-expected Q4 EPS and sales results.

#BIDU +6% Baidu, Inc. - reported better-than-expected Q3 EPS and sales results.

#MYOK +4% MyoKardia, Inc.


#PRTY -39% Party City Holdco Inc. -reported Q3 results.

#OBSV -30% ObsEva SA -said the results from the Phase 2 European confirmatory study of nolasiban in women undergoing embryo transfer following in-vitro fertilization did not meet the primary endpoint of an increase in ongoing pregnancy rate at 10 weeks.

#FOSL -28% Fossil Group, Inc. - reported Q3 EPS of $(0.51) compared to the $0.09 estimate and worse-than-expected sales results.

#RKDA -17% Arcadia Biosciences, Inc. - reported weaker-than-expected earnings for its third quarter.

#PBYI -15% Puma Biotechnology, Inc. - reported Q3 results.

#ROKU -14% Roku, Inc. -despite the company reporting better-than-expected Q3 EPS and sales results.

#EXPE -12% Expedia Group, Inc. - reported worse-than-expected Q3 EPS and sales results.

#INSG -11% Inseego Corp - reported worse-than-expected Q3 EPS results. The company also issued Q4 sales guidance below estimates.

#AGRX -11% Agile Therapeutics, Inc.

#VERI -10% Veritone, Inc. - reported Q3 results.

#HL -10% Hecla Mining Company - reported Q3 results.

#RP -10% RealPage, Inc. -reported Q3 results and to announced plans to acquire Buildium for $580 million in cash.

#RLGY -6% Realogy Holdings Corp. - reported worse-than-expected Q3 results and agreed to sell its global relocation business to SIRVA Worldwide, Inc.

#UPWK -6% Upwork Inc - narrowed the high end of FY19 sales guidance.

#CVNA -6% Carvana Co - reported Q3 earnings results.

#AGIO -5% Agios Pharmaceuticals Inc - reported a 7.5 million share common stock offering.